Synopsis
Highlights
History
Business
Property
Subsidiaries
Long term debt
Capital stock
Earnings estimates
Business segments
|
Business Summary
AngioDynamics designs, manufactures and sells a range of medical, surgical and diagnostic devices used by healthcare provider. Co.'s product offerings fall within Med Tech and Med Device segments. Co.'s technology products include auryon and thrombectomy platformwhich includes AngioVac, AlphaVac and thrombolytics atheters, and nanoknife. Co.'s Peripheral Products include angiographic products and accessories, drainage products, and micro access kits. Co. provides a variety of dialysis catheters, including: BioFlo DuraMax, which is a dialysis catheter with Endexo Technology; and DuraMax, which is a stepped-tip catheter.Pricing Summary
Time Period
Yesterday | 5 Days | 30 Days | |
---|---|---|---|
Close | 5.56 | 5.72 | 6.52 |
Volume | 488,056.00 | 491,740.00 | 288,521.00 |
52 Week High/Low : | 9.94 - 5.27 | ||
% Price Change (100 Days) : | -5.28 | ||
200-Day Moving Avg. : | 6.16 |
Company News
Corporate Events
Key Executives
Age | ||
---|---|---|
Chairman | 61 | |
Age | Salary | |
President,Chief Executive Officer | 58 | 736,154 |
Age | Salary | |
Executive Vice President,Chief Financial Officer,General Counsel | 48 | 409,692 |
Age | Salary | |
Senior Vice President | 59 | 360,529 |
Age | Salary | |
Senior Vice President,Division Officer | 51 | 324,146 |
Key Financials
(In USD as of 02/29/2024)Income Statement | |
---|---|
Revenue | 324m |
Net Income | -192m |
EPS from Continuing Operations | -4.78 |
EPS - Net Income - Diluted | -4.78 |
Revenue per Share | 8.05 |
Balance Sheet | |
Total Assets | 325m |
Total Liabilities | 106m |
Shareholders' Equity | 219m |
Total Assets per Share | 8.04 |
Net Assets per Share | 5.41 |
Cash Flows | |
Cash from Operations | -17m |
Cash from Investing | 125m |
Cash from Financing | -59m |
Capital Expenditures | 3m |
Cash Flow per Share | -0.43 |